Iovance Biotherapeutics
IOVA
IOVA
77 hedge funds and large institutions have $183M invested in Iovance Biotherapeutics in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 17 reducing their positions, and 16 closing their positions.
Holders
77
Holders Change
-5
Holders Change %
-6.1%
% of All Funds
2.05%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
11
Increased
29
Reduced
17
Closed
16
Calls
$2.95M
Puts
$422K
Net Calls
+$2.53M
Net Calls Change
-$3.64M
Top Buyers
1 |
1
Axa
Paris,
France
|
$4.04M |
2 |
ACP
2
Acuta Capital Partners
Redwood City,
California
|
$12.7M |
3 |
OAM
3
Oxford Asset Management
Oxford,
United Kingdom
|
$3.07M |
4 |
GTC
4
Ghost Tree Capital
New York
|
$1.27M |
5 |
QF
5
QVT Financial
New York
|
$8.12M |